AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic

Fatty Liver Disease

26
Clinical Trials
63
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT01707914
Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subjects With Features of Fatty Liver Disease
Completed
NCT01210989
Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis
Completed
NCT05637866
SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic Outcomes
Active_Not_Recruiting
📊 Sample Meta-Analyses
CRD42021232065
Sodium intake in relation with non-alcoholic fatty liver: A systematic review and meta-analysis of observational studies
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disorder a
CRD42017081750
Green tea as a safe alternative approach for non-alcoholic fatty liver treatment: a systematic review and meta-analysis
Patients who suffer from Non-alcoholic fatty liver disease (NAFLD).
CRD42022314590
The effects of purslane (Portulaca oleracea) on fasting blood sugar, liver enzymes, and dyslipidemia: A systematic review and meta-analysis of randomized clinical trials
We will investigate the effects of purslane on adult patients with dyslipidemia,
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Fatty Liver Disease
🏥 Names
Disease Name
Fatty Liver Disease
Topic Type
syndrome
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Disease or Syndrome
🔗 External References
DisGeNET
C4529962
🔍 Raw view — every non-empty column on this row (19 fields)
name
Fatty Liver Disease
topic type
syndrome
disgenet disease type
disease
umls disease type
Disease or Syndrome
umls disease type id
T047
herb disease id
HBDIS026981
disgenet id
C4529962

📋 Clinical Trials

12 · subject of clinical study
NCT01707914 Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subje
→ Nonalcoholic Fatty Liver Disease
NCT01210989 Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis
→ Nonalcoholic Fatty Liver Disease
NCT05637866 SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic Outcomes
→ Cardiovascular Diseases|Lipid Disorder|Metabolic D
NCT00633282 Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Dis
→ Nonalcoholic Fatty Liver Disease
NCT04049396 Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD)
→ Non-Alcoholic Fatty Liver Disease
NCT01934777 Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children
→ Fatty Liver|Liver Fibrosis|Obesity|Metabolic Syndr
NCT01934777 Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children
→ Fatty Liver|Liver Fibrosis|Obesity|Metabolic Syndr
NCT03864783 The Effect of Curcumin on Liver Fat Content in Obese Subjects
→ Non-Alcoholic Fatty Liver Disease|Insulin Resistan
NCT00389376 Phase I Trial of Silymarin for Chronic Liver Diseases
→ Hepatitis C|Non-Alcoholic Fatty Liver Disease
NCT03749070 Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease - The S
→ Non-Alcoholic Fatty Liver Disease
NCT04364360 Sulforaphane Supplementation Study
→ Non-Alcoholic Fatty Liver Disease|Obesity|Metaboli
NCT01446276 Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonal
→ Obesity|Nonalcoholic Fatty Liver Disease

📊 Meta-Analyses

12 · systematic review
CRD42021232065 Sodium intake in relation with non-alcoholic fatty liver: A systematic review an
→ Non-alcoholic fatty liver disease (NAFLD) is the m
CRD42017081750 Green tea as a safe alternative approach for non-alcoholic fatty liver treatment
→ Patients who suffer from Non-alcoholic fatty liver
CRD42022314590 The effects of purslane (Portulaca oleracea) on fasting blood sugar, liver enzym
→ We will investigate the effects of purslane on adu
CRD42016038081 Association between coronary artery calcium score and non-alcoholic fatty liver
→ The prevalence of nonalcoholic fatty liver disease
CRD42020212501 Effects of alpha-lipoic acid supplementation on non-alcoholic fatty liver diseas
→ Non-alcoholic fatty liver diseases (NAFLD)
CRD42020184592 efficiency and safety of berberine therapy in patients with non-alcoholic fatty
→ Efficacy of berberine against non-alcoholic fatty
CRD42021277602 Therapeutic effects and mechanisms of action of berberine on in Non-alcoholic fa
→ Non-alcoholic fatty liver disease (NAFLD), one of
CRD42022345481 Correlation between serum bile acid and nonalcoholic fatty liver disease: A Syst
→ Nonalcoholic fatty liver disease has become the mo
CRD42022361187 Relationship between copper level and nonalcoholic fatty liver disease: A System
→ To study the relationship between serum copper lev
CRD42018090633 Does turmeric and/or curcumin supplementation improves liver enzymes in non-alco
→ non alcoholic fatty liver disease
CRD42018111638 Does turmeric and/or curcumin supplementation reduce BMI and/or weight in non-al
→ Turmeric or curcumin supplementation in patients w
CRD42021247600 The effects of curcumin supplementation on metabolic biomarkers and body mass in
→ Non-alcoholic fatty liver disease (NAFLD) is the m
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
  • Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
  • Target ↔ Disease: ACTIVE — direct link via target_health_topics
  • Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables